Processa Pharmaceuticals, Inc.
PCSA
$1.99
-$0.17-7.87%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 196.30K | 1.69M | 5.54M | 6.31M | 6.94M |
| Total Receivables | -- | -- | -- | 19.00K | 29.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.40M | 247.40K | 133.90K | 259.30K | 188.20K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 472.00K | -- | -- | -- | -- |
| Total Current Assets | 2.07M | 1.94M | 5.67M | 6.59M | 7.15M |
|
|
|||||
| Total Current Assets | 2.07M | 1.94M | 5.67M | 6.59M | 7.15M |
| Net Property, Plant & Equipment | 3.20K | 3.50K | 3.80K | 4.10K | 28.70K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 2.58M | 2.14M | 993.70K | 999.20K |
| Total Assets | 2.07M | 4.52M | 7.81M | 7.58M | 8.18M |
|
|
|||||
| Total Accounts Payable | 1.66M | 840.40K | 1.06M | 727.20K | 785.80K |
| Total Accrued Expenses | 727.50K | 1.14M | 1.18M | 1.02M | 1.26M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | 25.60K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 2.39M | 1.98M | 2.24M | 1.75M | 2.07M |
|
|
|||||
| Total Current Liabilities | 2.39M | 1.98M | 2.24M | 1.75M | 2.07M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.39M | 1.98M | 2.24M | 1.75M | 2.07M |
|
|
|||||
| Common Stock & APIC | 107.11M | 106.70M | 106.66M | 103.56M | 100.39M |
| Retained Earnings | -107.43M | -104.16M | -100.78M | -97.42M | -93.99M |
| Treasury Stock & Other | -- | -- | -300.00K | -300.00K | -300.00K |
| Total Common Equity | -317.30K | 2.54M | 5.58M | 5.83M | 6.11M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -317.30K | 2.54M | 5.58M | 5.83M | 6.11M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -317.30K | 2.54M | 5.58M | 5.83M | 6.11M |
|
|
|||||